SVS — Svas Biosana SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €44.34m
- €89.27m
- €120.31m
- 35
- 94
- 81
- 85
Annual cashflow statement for Svas Biosana SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.51 | 3.16 | 3.57 | 5.13 | 5.88 |
| Depreciation | |||||
| Non-Cash Items | 3.66 | 3.42 | 4.3 | 1.91 | 4.69 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.88 | -8.58 | -7.77 | -7.76 | -10.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.31 | 2.53 | 4.88 | 4.29 | 5.14 |
| Capital Expenditures | -1.9 | -5.92 | -4.87 | -5.83 | -6.13 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.723 | -0.107 | -8.7 | 2.68 | 3.26 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.62 | -6.02 | -13.6 | -3.15 | -2.88 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.97 | 27.4 | -0.117 | 11.5 | -3.12 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.66 | 23.9 | -8.81 | 12.6 | -0.853 |